Immediate Impact
1 by Nobel laureates 11 from Science/Nature 50 standout
Citing Papers
Exploring treatment options in cancer: tumor treatment strategies
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of Markus Falk being referenced
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy
2022
RXDX-106 Is an orally-available, potent and selective TAM/MET inhibitor demonstrating preclinical efficacy in MET-dependent human malignancies
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Markus Falk | 200 | 218 | 342 | 55 | 767 | |
| Sven Gunia | 257 | 166 | 443 | 67 | 872 | |
| Martijn G. Steffens | 322 | 130 | 193 | 51 | 837 | |
| Yutaka Enomoto | 309 | 219 | 253 | 60 | 702 | |
| Katsunori Uchida | 280 | 216 | 232 | 76 | 743 | |
| Taketo Kawai | 222 | 258 | 379 | 97 | 786 | |
| Philip H. Kim | 374 | 200 | 463 | 30 | 947 | |
| Bishoy A. Gayed | 451 | 138 | 353 | 45 | 885 | |
| Orhan G. Yigitbasi | 277 | 314 | 176 | 48 | 952 | |
| Maria Luisa Policarpio‐Nicolas | 199 | 215 | 554 | 59 | 911 | |
| Katsuya Aoki | 152 | 225 | 372 | 52 | 817 |
All Works
Login with ORCID to disown or claim papers
Loading papers...